Search

everythinglearnresearchcommunity

for

Search:↓

Lichen planopilaris (LPP) is linked to androgen excess, while frontal fibrosing alopecia (FFA) is linked to androgen deficiency.

Lower MC2R expression may contribute to alopecia areata.

AMT may cause hair loss and changing dWAT activity could help treat it.

High beta-hydroxybutyrate levels may worsen hair loss in alopecia areata.

CD4 T cells can cause alopecia areata by activating CD8 T cells to attack hair follicles.

Different γδ T cell types have unique roles in causing alopecia areata.

Oxidative stress and mitophagy play key roles in hair loss, suggesting potential treatment targets.

Linalool in fragrances may harm hair follicles and contribute to hair loss.

A specific gene change is linked to severe hair loss.

Adalimumab may cause severe hair loss in some patients.

People with Alopecia Areata have lower vitamin D levels.

DHT, a testosterone byproduct, causes male pattern baldness.

Alopecia areata is a common autoimmune disease affecting hair follicles, with unclear causes and a need for better treatments.

A substance called VIP might protect hair follicles from being attacked by the immune system, and problems with VIP signaling could lead to hair loss in alopecia areata.

iNKT cells can help prevent and treat alopecia areata by promoting hair regrowth.

The document concludes that primary scarring alopecias cause permanent hair loss, have unpredictable outcomes, and lack definitive treatments, requiring personalized care.

ILC1-like cells can independently cause alopecia areata.

Male pattern baldness involves hormone-related hair thinning, shorter hair, and inflammation.

Blocking interferon-gamma helps prevent and treat hair loss in Alopecia Areata.

More research is needed to understand and treat cicatricial alopecias.

The document concludes that treatments for female hair loss and excessive hair growth are temporary and not well-studied.

The conditions alopecia areata, primary sclerosing cholangitis, and ulcerative colitis may be linked by shared autoimmune and cell death mechanisms.

Five molecular elements identified as potential future targets for hair loss therapy.

New treatments for hair loss are being developed using molecular biology.

Alopecia areata causes varying hair loss and nail changes, and treatments include topical, systemic, and injectable therapies.

PPARα agonists may help treat alopecia areata by reducing inflammation.

Certain genetic factors may contribute to frontal fibrosing alopecia in Brazil.

Chemotherapy-induced hair loss may be linked to immune system changes, and certain treatments could help but need careful use.

Gut microbiota changes might play a role in alopecia areata, and microbiome-targeted treatments show promise.

Higher substance P levels may cause discomfort in hair loss patients.